Approval · Notice of Compliance 1305 · 2000
BONAMINE: Notice of Compliance 1305
Issued July 12, 2000
A Notice of Compliance is Health Canada’s approval of a drug submission: a new drug, a new use or form, or a change to an approved one. The product itself is in the Drug Product Database, with its current status.
- Notice number
- 1305
- Date
- July 12, 2000
- Company
- Pfizer Canada Inc., Consumer Healthcare DivisionMarkham, Ontario, Canada
- Product type
- Nonprescription Pharmaceutical
- Submission
- New Drug Submission (NDS)
- Submission class
- Admin
- Therapeutic class
- Antiemetic
Products in this notice
| Brand | DIN | Status today |
|---|---|---|
| BONAMINE | 00220442 | Cancelled Post Market |
Medicinal ingredients
- MECLIZINE HYDROCHLORIDE 25 MG per TAB